Preliminary testing shows positive results towards using CBD as an antibiotic topically, but also potentially to deal with systematic infections, such as pneumonia, using oral dosing. One of the present concerns is the struggle of getting permits to handle these cannabinoids to do further testing.
While these specific findings have not yet been published in a peer-review journal, this is far from the first time we have seen antimicrobial activity associated with plants or with cannabis. Evolutionarily, this trait is believed to be adaptive for the plant, and within cannabinoid, terpenoid, and flavonoid compounds, this activity has been demonstrated reproducibly, both in the lab and in clinic. http://bit.ly/2LbTwxm
To explore related information, check the CED Foundation MMJ archive to search, or click the keywords below:
Benjamin Caplan, MDCBD antibacterial properties, topically
Exciting note to Massachusetts medical cannabis patients: Beginning July 1, medical patients will have the opportunity for an “Initial Access Certification” once they have seen their certifying physician. This access is good for 14 days, so patients will no longer have to wait for the state approval process before having access to medication. More info: http://bit.ly/2LmFY1Q
View the full documentation (yellow link) or download:
Long-term medical cannabis use and risk factors for diversion- report on physician’s guidance and patients’ behaviour
A recent examination of long-term medical cannabis users has demonstrated the need for more consistent training of storage and disposal practices from oncologists. Chronic users tend to increase the dosage taken of medical cannabis over time due to tolerance; higher doses of cannabis are associated with dangerous storage and disposal practices. The current study calls for oncologists who recommend cannabis-based medicine to their patients to have more consistent training in safe storage and disposal methods to prevent patients from ingesting or giving away impure cannabis.
An important point brought up in this article is the pressure some patients experience from their peers to buy cannabis for multiple people with their medical marijuana identification card or certification. Physicians should be wary of this practice and support their patients, reminding them of the accidents that can happen when medications are shared.
Euphorbia honey and garlic- Biological activity and burn wound recovery
A recent study has shown that a combination of euphorbia honey and garlic can help heal burn wounds. Euphorbia honey and garlic have antioxidant, microbial, and healing properties that have now been confirmed to be effective when treating wounds resulting from exposure to extreme heat. Combining natural ingredients has been common in traditional medicine for years, but now western medicine is beginning to look at more natural compounds to aid in recovery and treatment methods.
Flavonoids in common and Tartary Buckwheat hull extracts and antioxidant activity of the extracts against lipids in mayonnaise
A recent study has revealed that the various flavonoids in buckwheat hulls are a reliable source for antioxidant material. When a buckwheat hull extract was made and exposed to mayonnaise, the shelf-life of the mayonnaise was extended, likely related to the antioxidant properties. This study was able to determine the effectiveness of extracts from the common and Tartary Buckwheat hulls, as well as provide an efficient extraction method.
Efficacy and safety of cannabidiol followed by an open-label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomized, placebo-controlled study
Current researchers have proposed a study protocol that would expose any possible benefits of cannabidiol (CBD) and tetrahydrocannabinol (THC) for the treatment of chronic pain in patients suffering from rheumatoid arthritis (RA) and ankylosing spondylitis (AS). This new study hopes to identify how medical cannabis affects pain and cognitive function in RA and AS and provide evidence that cannabis-based pain medication is an alternative to opioids with fewer risks.
A recently published study looking to expose the functional status of older drug users has found that most of their cognitive abilities are equal to their peers who have never smoked cocaine, except for a marginally lower verbal comprehension. Similar studies should continue in order to determine how chronic drug users will affect or challenge public health systems in the future.
When the CEOs of major cannabis companies were asked what they believed the biggest threats to the cannabis industry are, the answers were consistent with common concerns: black market cannabis, public policy, execution of businesses, as well as consistency of product and markets. Not only in the US, but also globally https://yhoo.it/31pNOO9
To explore related information, click the keywords below:
Benjamin Caplan, MDCommon Concerns for cannabis CEOs
A recent study has found that flavonoids isolated from Psoralea corylifolia are able to inhibit part of the insulin pathway.
Seeds of the P. corylifolia plant have been used in eastern medicine, primary in China, for years, and is now being further researched as flavonoids continue to intrigue researchers with their possible therapeutic benefits. The inhibitory activity found in this study provides evidence that flavonoids should be pursued as a potential treatment for Type-2 Diabetes.
While most people tout market projections, this CEO notes that many people entering the industry have not considered the logistics behind creating and expanding their business. In such a unique industry, realistic goals and measures will be crucial to long term success and scaling. http://bit.ly/31fJYH0
Benjamin Caplan, MDMarket Projections, Ethanol Extraction, and Mismatched Expectations